Patents by Inventor Weston J. Hale

Weston J. Hale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-pathogenic therapeutic compositions
    Patent number: 11065220
    Abstract: Therapeutic compounds useful for the treatment of pathogens including bacteria (gram positive and gram negative, mycobacteria), some fungi and viruses. The compounds described herein may include a mixture of therapeutically-effective amounts of a polar amino acid, a CI 1 fatty acid, and an anthraquinone. The invention further provides for the administration of the therapeutic compounds to a patient (e.g., a human) suffering from an infection.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: July 20, 2021
    Assignee: Wintermute Biomedical, Inc.
    Inventors: Weston J. Hale, Thomas F. Rau
  • ANTI-PATHOGENIC THERAPEUTIC COMPOSITIONS
    Publication number: 20200046666
    Abstract: Therapeutic compounds useful for the treatment of pathogens including bacteria (gram positive and gram negative, mycobacteria), some fungi and viruses. The compounds described herein may include a mixture of therapeutically-effective amounts of a polar amino acid, a CI 1 fatty acid, and an anthraquinone. The invention further provides for the administration of the therapeutic compounds to a patient (e.g., a human) suffering from an infection.
    Type: Application
    Filed: February 13, 2018
    Publication date: February 13, 2020
    Applicant: WINTERMUTE BIOMEDICAL, INC.
    Inventors: Weston J. HALE, Thomas F. RAU
  • Therapeutic compounds
    Patent number: 10195242
    Abstract: The invention features therapeutic compounds useful for the treatment of skin diseases (e.g., psoriasis and eczema), infections (microbial, viral, and fungal), and wounds (e.g., cuts and burns). The compounds of the invention include therapeutically-effective amounts of L-Arginine, undecylenic acid, and Rheum Officinale extract. The invention further provides for the administration of the therapeutic compounds to a patient (e.g., a human) suffering from a skin disease, infection, or wound.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: February 5, 2019
    Assignee: Wintermute Biomedical, Inc.
    Inventors: Weston J. Hale, Thomas F. Rau
  • Therapeutic Compounds
    Publication number: 20150366925
    Abstract: The invention features therapeutic compounds useful for the treatment of skin diseases (e.g., psoriasis and eczema), infections (microbial, viral, and fungal), and wounds (e.g., cuts and burns). The compounds of the invention include therapeutically-effective amounts of L-Arginine, undecylenic acid, and Rheum Officinale extract. The invention further provides for the administration of the therapeutic compounds to a patient (e.g., a human) suffering from a skin disease, infection, or wound.
    Type: Application
    Filed: January 27, 2014
    Publication date: December 24, 2015
    Applicant: Wintermute Biomedical, LLC
    Inventors: Weston J. Hale, Thomas F. Rau